DCCC Defense of Anti-Gay, Anti-Choice Democrat Sparks Pushback
“Dan Lipinski needs to go and Marie came within 1,600 votes of defeating him with progressive support in 2018.”
Politics
Washington Becomes First State to Approve Publicly Funded Long-Term Care
The measure is hailed as a monumental achievement for advocates working nationally to tackle the rising and formidable costs of care work and old age.
PhRMA Is Funding a Democratic Think Tank Trying to Derail Medicare for All
PhRMA’s contributions to the Third Way Foundation peaked in 2016 when Bernie Sanders first put Medicare for All on the map.
Joe Biden Launches Presidential Bid With Fundraiser Filled With Corporate Lobbyists and GOP Donors
Joe Biden, like other Democratic candidates, pledged not to take lobbyist money, but his first fundraiser will be rife with cash from corporate interests.
Young Democrats at 40 College Campuses Call for Boycott of the DCCC
Led by the Harvard College Democrats, students are protesting the DCCC’s policy of blacklisting consultants who work with primary challengers.
Voices
Being Rupert Murdoch: How the Founder of Fox News Spreads His Brand of Destruction
“Ink,” a play about Rupert Murdoch, reveals his tactic of disruption by proxy. He lurks in the background as his employees spread far-right ideas.
The “Shelby Mafia” Is Muscling Through a Major New Bank Merger
Sen. Richard Shelby has managed to stock key positions with loyalists across industry and government.
Beto O’Rourke Was Threatening to Run a New Kind of Campaign. Not Anymore.
By parting ways with 2016 Bernie Sanders campaign alumni, O’Rourke took another step toward reshaping himself as a more mainstream candidate.
Benjamin Netanyahu Plans to Name an Illegal Settlement in Donald Trump's Honor
If Bernie Sanders wins the Democratic nomination, expect Benjamin Netanyahu to act more like Donald Trump's running mate than an impartial observer.
Nancy Pelosi’s Drug-Pricing Talks With the Trump Administration Are About Mediating Fights Between Corporate Interests
Lobbyist Lauren Aronson has been working closely with a top Pelosi aide and in consultation with the Trump administration to find a drug-pricing compromise.